[1]池里群.基于药物研发与药物临床试验评价孕妇受试者的风险防控[J].医学信息,2020,33(02):11-12,21.[doi:10.3969/j.issn.1006-1959.2020.02.003]
　CHI Li-qun.Evaluation of Risk Prevention and Control for Pregnant Subjects Based on Drug Development and Clinical Trials[J].Medical Information,2020,33(02):11-12,21.[doi:10.3969/j.issn.1006-1959.2020.02.003]
点击复制

基于药物研发与药物临床试验评价孕妇受试者的风险防控()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年02期
页码:
11-12,21
栏目:
出版日期:
2020-01-15

文章信息/Info

Title:
Evaluation of Risk Prevention and Control for Pregnant Subjects Based on Drug Development and Clinical Trials
文章编号:
1006-1959（2020）02-0011-03
作者:
池里群
（北京市海淀区妇幼保健院药剂科，北京 100080）
Author(s):
CHI Li-qun
(Department of Pharmacy,Haidian District Maternal and Child Health Hospital,Beijing100080,China)
关键词:
孕妇; 伦理审查; 药物临床试验; 风险防控
Keywords:
Pregnant women; Ethical review; Drug clinical trials; Risk prevention and control
分类号:
R-052
DOI:
10.3969/j.issn.1006-1959.2020.02.003
文献标志码:
B
摘要:
自从我国全面“二胎”生育政策实施以来，孕妇临床用药需求也随之增加，但是目前可为其提供的专用药品范围十分有限。为了解决这一问题，临床需加大加强新药研发的力度。孕妇作为一种特殊群体，做好孕妇受试者的风险防控、设计科学合理的药物临床试验方案并严格规范执行是孕妇用药研发需要解决的重要问题。本文现就孕妇作为受试者如何科学地参与临床药物研发这一内容进行探讨。
Abstract:
Since the implementation of China’s comprehensive "second child" fertility policy,the demand for pregnant women’s clinical medication has also increased. However, the range of specialty medicines available to them is currently very limited.In order to solve this problem,clinical efforts need to increase the intensity of new drug development.As a special group of pregnant women,it is an important issue for pregnant women’s drug research and development to do a good job in risk prevention and control of pregnant women subjects,to design scientific and rational drug clinical trial schemes,and to strictly implement them.This article discusses how pregnant women as subjects participate scientifically in clinical drug development.

参考文献/References:

[1]田剑波.医学临床试验中受试者法律保护的现状与完善[J].医学与法学,2017,9(4):36-40. [2]蓝雪容,古润玲,欧伟红.某院妇产科门诊超说明书用药分析[J].今日药学,2019,29(6):395-397. [3]陈画虹,范玉华,黎张燕,等.某院妇产科门诊超说明书用药情况调查与分析[J].中国药业,2019,28(15):85-88. [4]何晓静,邵颖,于丹,等.某院门诊妊娠患者超说明书用药情况分析[J].中国医院药学杂志,2018,38(4):436-439. [5]刘薇芝.终止妊娠药品临床超说明书用药分析及探讨[J].中南药学,2019,17(8):1354-1358. [6]郭俊荣,张方.美法两国对超说明书用药监管对策及其借鉴启示[J].中国药物应用与监测,2019,16(1):46-49. [7]杜博冉,冯欣,史湘君.美国FDA新孕妇用药规则的实行及影响[J].中国药学杂志,2016,51(12):1049-1054. [8]江一峰,耿雯倩,祝延红,等.临床试验中的弱势群体及其伦理保护[J].医学与哲学,2017,38(6):25-27. [9]王富海,张爱珍,曾彩贤,等.胎儿药源性疾病与孕妇不合理用药的相关性分析[J].抗感染药学,2017,14(6):1109-1112. [10]刘水冰,刘雷,王东光.药物在临床前及临床试验研究中的伦理问题综述[J].中国医学伦理学,2017,30(4):491-494. [11]国家食品药品监督管理总局食品药品审核查验中心,上海药品审评核查中心.美国FDA药物临床试验与非临床研究警告信汇编(2008～2017)[M].北京:中国医药科技出版社,2018:1-5.

相似文献/References:

[1]徐 敏,周 人,王慧萍.伦理委员会中精细化管理模式的应用与实践[J].医学信息,2022,35(10):26.[doi:10.3969/j.issn.1006-1959.2022.10.005]
　XU Min,ZHOU Ren,WANG Hui-ping.Application and Practice for Refined Management of Ethics Committee[J].Medical Information,2022,35(02):26.[doi:10.3969/j.issn.1006-1959.2022.10.005]
[2]王雪萍,张凤芹,李月凤,等.面向乡村孕妇的产前保健方法及产检结果分析[J].医学信息,2018,31(14):129.[doi:10.3969/j.issn.1006-1959.2018.14.039]
　WANG Xue-ping,ZHANG Feng-qin,LI Yue-feng,et al.Analysis of Prenatal Care Methods and Results of Birth Inspection for Pregnant Women in Rural Areas[J].Medical Information,2018,31(02):129.[doi:10.3969/j.issn.1006-1959.2018.14.039]
[3]李 丽.妊娠期高血压的发病特点及危险因素分析[J].医学信息,2019,32(18):71.[doi:10.3969/j.issn.1006-1959.2019.18.022]
　LI Li.Analysis of the Characteristics and Risk Factors of Hypertensive Disorder in Pregnancy[J].Medical Information,2019,32(02):71.[doi:10.3969/j.issn.1006-1959.2019.18.022]
[4]史爱红,刘爱玲,封 玲,等.凝血功能指标对不同类型子痫前期的诊断价值[J].医学信息,2020,33(21):90.[doi:10.3969/j.issn.1006-1959.2020.21.026]
　SHI Ai-hong,LIU Ai-ling,FENG Ling,et al.The Diagnostic Value of Coagulation Function Indexes for Different Types of Preeclampsia[J].Medical Information,2020,33(02):90.[doi:10.3969/j.issn.1006-1959.2020.21.026]
[5]廖熙茜.定期营养指导对围产期孕妇体重管理及妊娠结局的影响[J].医学信息,2023,36(24):95.[doi:10.3969/j.issn.1006-1959.2023.24.020]
　LIAO Xi-xi.Effect of Regular Nutrition Guidance on Weight Management and Pregnancy Outcome of Perinatal Pregnant Women[J].Medical Information,2023,36(02):95.[doi:10.3969/j.issn.1006-1959.2023.24.020]

更新日期/Last Update: 2020-01-15